COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,424 Articles (22,835 medRxiv, 8,589 bioRxiv)

Most recent first Previous |  Page 1559: Articles 15581-15590  | Next

Severity assessment of single dose Oxford-AstraZeneca vaccinated individuals infected with SARS CoV-2 in the Southeast Bangladesh
Rana, E. A., Dutta, P., Islam, M. S., Nizami, T. A., Das, T., Chowdhury, S., Das, G. B.
10.1101/2021.05.10.21256529 — Posted: 2021-05-11
Resuming In-Person Classes under COVID-19: Evaluating Assigned Seating Protocols in Limiting Contacts at Postsecondary Institutions
Daly-Grafstein, D., Daly, P., Gustafson, R.
10.1101/2021.05.07.21256844 — Posted: 2021-05-11
multiSero: open multiplex-ELISA platform for analyzing antibody responses to SARS-CoV-2 infection
Byrum, J. R., Waltari, E., Janson, O., Guo, S.-M., Folkesson, J., Chhun, B. B., Vinden, J., Ivanov, I. E., Forst, M. L., Li, H., Larson, A. G., Wu, W., Tato, C. M., McCutcheon, K. M., Peluso, M. J., Henrich, T. J., Deeks, S. G., Prakash, M., Greenhouse, B., Pak, J. E., Mehta, S. B.
10.1101/2021.05.07.21249238 — Posted: 2021-05-11
The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population. A survey of routine laboratory RT-PCR test results from the region of Muenster, Germany
Stang, A., Robers, J., Schonert, B., Joeckel, K.-H., Spelsberg, A., Keil, U., Cullen, P.
10.1101/2021.05.06.21256289 — Posted: 2021-05-11 Discussion: Onsite
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
Harrington, P., de Lavallade, H., Doores, K., O'Reilly, A., Seow, J., Graham, C., Lechmere, T., Radia, D., Dillon, R., Shanmugharaj, Y., Espehana, A., Woodley, C., Saunders, J., Curto Garcia, N., O'Sullivan, J., Raj, K., Kordasti, S., Malim, M. H., Harrison, C. N., McLornan, D.
10.1101/2021.04.27.21256096 — Posted: 2021-05-11
SARS-CoV-2 infection induces autoimmune antibody secretion more in lean than in obese COVID-19 patients
Frasca, D., Reidy, L., Romero, M., Diaz, A., Cray, C., Kahl, K., Blomberg, B.
10.1101/2021.05.05.21256686 — Posted: 2021-05-11
Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases
Taquet, M., Husain, M., Geddes, J. R., Luciano, S., Harrison, P.
10.1101/2021.04.27.21256153 — Posted: 2021-05-11 Discussion: Onsite
SARS-CoV-2 receptor ACE2 identifies immuno-hot tumors in breast cancer
Mei, J., Cai, Y., Xu, R., Yu, X., Chen, L., Ma, T., Gao, T., Gao, F., Zhu, Y., Zhang, Y.
10.1101/2021.05.10.443377 — Posted: 2021-05-10
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant
Edara, V.-V., Lai, L., Sahoo, M., Floyd, K., Sibai, M., Solis, D., Flowers, M. W., Hussaini, L., Ciric, C. R., Bechnack, S., Stephens, K., Mokhtari, E. B., Mudvari, P., Creanga, A., Pegu, A., Derrien-Colemyn, A., Henry, A. R., Gagne, M., Graham, B. S., Wrammert, J., Douek, D. C., Bortiz, E., Pinsky, B. A., Suthar, M.
10.1101/2021.05.09.443299 — Posted: 2021-05-10
A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery
Pinto, D., Sauer, M. M., Czudnochowski, N., Low, J. S., Tortorici, M. A., Housley, M. P., Noack, J., Walls, A. C., Bowen, J. E., Guarino, B., Rosen, L. E., di Iulio, J., Jerak, J., Kaiser, H., Islam, S., Jaconi, S., Sprugasci, N., Culap, K., Abdelnabi, R., Foo, C. S.-Y., Coelmont, L., Bartha, I., Bianchi, S., Silacci-Fregni, C., Bassi, J., Marzi, R., Vetti, E., Cassotta, A., Ceschi, A., Ferrari, P., Cippa', P. E., Giannini, O., Ceruti, S., Riva, A., Benigni, F., Cameroni, E., Piccoli, L., Pizzuto, M. S., Smithey, M., Hong, D., Telenti, A., Lempp, F. A., Neyts, J., Havenar-Daughton, C., Lanzave
10.1101/2021.05.09.442808 — Posted: 2021-05-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).